A simplified three-dose i.m. regimen for severe malaria in African children is non-inferior to the more complex WHO-recommended regimen.
This study contributes to the ongoing surveillance of suspected artemisinin resistance parasites in Africa by providing baseline prevalence of k13-propeller mutations in western Kenya with samples collected from a longitudinal study.
For an effective malaria control in this area, interventions should be formulated and implemented to target asymptomatic parasite reservoirs; especially in children and people with Hb AC.
These data indicate that plasma levels of haemin and haemopexin measured at presentation correlate with malaria severity and levels of haemin and cell-free haemoglobin predict outcome in paediatric severe malaria.
Malaria may be subject to socio-economic forces arising from a broad set of behavioural and geographic determinants, even after adjusting for geographic risk factors and seasonality.
In this study group, four in 10 and one in 10 children were found stunted and underweight, respectively, in an area of low malaria transmission.
In accordance with international targets, the Uganda National Malaria Control Strategic Plan established specific targets to be achieved by 2010.
User fees abolition reduced visit delay for febrile children living close to health centers.
Artesunate is more effective than quinine in the treatment of severe malaria in Cameroonian children.
This first randomized study in Brazzaville confirmed the excellent efficacy of these co-formulated anti-malarial drugs in children.
